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ABSTRACT Hospital-acquired infection is a major cause of morbidity and mortality, and
regimes to prevent infection are crucial in infection control. These include the decoloni-
zation of vulnerable patients with methicillin-resistant Staphylococcus aureus (MRSA) car-
riage using antiseptics, including chlorhexidine and octenidine. Concern has been raised,
however, regarding the possible development of biocide resistance. In this study, we as-
sembled a panel of S. aureus isolates, including isolates collected before the develop-
ment of chlorhexidine and octenidine and isolates, from a major hospital trust in the
United Kingdom during a period when the decolonization regimes were altered. We ob-
served signiﬁcant increases in the MIC and minimum bactericidal concentration (MBC) of
chlorhexidine in isolates from periods of high usage of chlorhexidine. Isolates with in-
creased MICs and MBCs of octenidine rapidly emerged after octenidine was introduced
in the trust. There was no apparent cross-resistance between the two biocidal agents. A
combination of variable-number tandem repeat (VNTR) analysis, PCR for qac genes, and
whole-genome sequencing was used to type isolates and examine possible mechanisms
of resistance. There was no expansion of a single strain associated with decreased bio-
cide tolerance, and biocide susceptibility did not correlate with carriage of qac efﬂux
pump genes. Mutations within the NorA or NorB efﬂux pumps, previously associated
with chlorhexidine export, were identiﬁed, however, suggesting that this may be an im-
portant mechanism of biocide tolerance. We present evidence that isolates are evolving
in the face of biocide challenge in patients and that changes in decolonization regimes
are reﬂected in changes in susceptibility of isolates.
IMPORTANCE Infection in hospitals remains a major cause of death and disease.
One way in which we combat this is by decolonizing at-risk patients from carriage
of bacteria which can cause disease such as MRSA. This is done with antiseptics, in-
cluding chlorhexidine and octenidine. There is concern, however, that bacteria may
be able to become resistant to these antiseptics. In this study, we looked at isolates
of MRSA and found that there was a correlation between the use of antiseptics and
increased resistance in the isolates. We also suggest that the mechanism by which
these more tolerant isolates may become resistant to antiseptics is that of changing
a transport pump that exports these agents. This information suggests that we need
to study the impact of antiseptics on clinically important bacteria more closely.
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Antiseptics, and especially chlorhexidine, have been used widely as one of the keymeasures implemented in the control of infections caused by methicillin-resistant
Staphylococcus aureus (MRSA) in hospitals. The most widely used approach has been to
use antiseptics as part of a decolonization protocol in conjunction with nasal mupirocin
for patients who are known to be colonized with MRSA. However, in some units,
especially intensive care units, antiseptics have been used universally for washing of all
patients (1).
Chlorhexidine, which was ﬁrst synthesized in 1954 (2), is the most widely used
antiseptic. It is a cationic biguanide agent that acts by disrupting the bacterial cell
membrane. A more recent introduction to clinical practice is octenidine dihydrochlo-
ride, which was synthesized over 30 years later (3). Like chlorhexidine, it is a cationic
biguanide agent that has a broad spectrum of activity.
Chlorhexidine and other quaternary ammonium compounds are widely used, being
key active components of preservatives and disinfectants (4). They are generally stable,
and environmental accumulation is now common, which has led to concerns being
raised over the potential for development of resistance (5, 6). Selection of mutants that
are resistant to the simpler quaternary ammonium compounds has proved relatively
easy under laboratory conditions (7).
Determination of chlorhexidine susceptibility has most often relied on data from
MIC determinations. Determination of the MIC is, however, an imperfect method
for testing biocide resistance under circumstances in which the lethal rather than the
inhibitory concentration of the agent is of primary importance and needs to be
measured. In addition, there is no agreed-upon standardized testing methodology and
no national or international agreement regarding an appropriate cutoff value for
deﬁning chlorhexidine resistance. However, studies have often deﬁned isolates with a
chlorhexidine MIC of 4 mg/liter as representing resistance (8). No deﬁnition has been
proposed for octenidine.
The mechanisms of action and resistance to biocides, including chlorhexidine,
remain poorly understood, although there are several genes that encode efﬂux pumps
which have been shown to be able to inﬂuence biocide susceptibility. Of these, qacA
is the gene most commonly associated with reduced susceptibility to chlorhexidine in
staphylococci. However, the presence of qacA does not necessarily result in expression
of resistance to chlorhexidine and, conversely, resistance can be expressed without the
presence of qacA (9–11).
Most studies that have investigated reduced susceptibility to biocides have studied
chlorhexidine. The limited numbers of studies that have investigated octenidine have
looked at the clinical efﬁcacy and have not included susceptibility testing as part of
their studies, with the only in vitro study failing to select for resistance to octenidine
dihydrochloride (12–14). In contrast to octenidine, reduced susceptibility has been
described in chlorhexidine, with the prevalence rates differing between studies (8). Few
longitudinal studies have been reported, but one performed in Taiwan observed an
increase in the percentage of MRSA strains with reduced susceptibility to chlorhexidine
from 1.7% to 46.7% from 1990 to 2005 (15), while signiﬁcant increases in the chlo-
rhexidine MIC between 1989 and 2000 for both methicillin-susceptible S. aureus (MSSA)
isolates and MRSA isolates were observed by Lambert (16). Warren et al. observed a
nonlinear increase in the presence of qacA- and qacB (qacA/B)-positive isolates, with
marked increases in years 5 and 6 of their study but decreases in the subsequent 2 years
(17). There have also been case reports of the selection of isolates with an increase in
the chlorhexidine MIC in patients receiving chlorhexidine as part of a decolonization
regime (18).
Despite the reporting of isolates with reduced antiseptic susceptibility, the clinical
impact of this is unclear, with antiseptics being used at much higher concentrations
than the typical MIC or minimum bactericidal concentration (MBC) of these isolates.
However, there have been reports of clinical failures of decolonization, including both
an outbreak of a speciﬁc clone of MRSA that had decreased susceptibility to chlorhexi-
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dine and the persistence of a hospital clone that carried qacA and outcompeted a
non-qacA-carrying clone (19–21).
This study aimed to investigate whether susceptibility to chlorhexidine and octeni-
dine dihydrochloride, the two biocides most commonly used for the decolonization of
patients colonized with MRSA, varied in a unique panel of S. aureus strains isolated over
an extended period during which chlorhexidine use increased and octenidine use was
introduced (Table 1).
RESULTS
Usage of chlorhexidine and octenidine. The use of chlorhexidine and octenidine
was analyzed in our hospital, with the results showing a decrease in usage of chlo-
rhexidine and an increase in octenidine use across the study period. The usage of
chlorhexidine decreased from 7,061 packs being dispensed in 2009 to 5,091 in 2014. In
contrast, the usage of octenidine dihydrochloride increased markedly, with none being
prescribed in or before 2013 and 18,844 bottles being prescribed in 2014.
Biocide susceptibility of isolates. The MIC and MBCs of chlorhexidine were signif-
icantly different across the four groups (Table 2 and Table 3). Chlorhexidine MICs
ranged from 0.5 g/ml to 32 g/ml and chlorhexidine MBCs from 2 g/ml to 64 g/ml.
The mean MIC and MBC of chlorhexidine increased over time from group 1 to group
3 and then plateaued in group 4. The mean MBC of chlorhexidine increased approxi-
mately 3-fold (from 5.8 g/ml to 16.5 g/ml) between group 1 and group 3 (P 
0.0001); group 4 had a slightly lower mean MBC (15.6 g/ml) than group 3, although
the difference was not signiﬁcant (P 0.78). The increases in mean MIC and MBC values
were a result of a shift of susceptibility of most isolates in the population, requiring
higher MICs or MBCs, rather than of the presence of a small subpopulation of highly
resistant isolates (Fig. 1 and 2). For example, the proportions of isolates with an MBC
of 32 g/ml increased from group 1 to group 2 to group 3 (0% to 1.6% to 31.2% of
isolates, respectively) (Fig. 2). The differences between the higher MIC and MBC
distributions seen in groups 3 and 4 were not likely to be random according to
statistical tests (chi-square and Mann-Whitney tests both returned P values of 0.05 in
comparisons of both group 3 and group 4 to either group 1 or group 2).
In contrast to the results seen for chlorhexidine, the mean MIC and MBC of
octenidine did not rise with time across groups 1 to 3 (the only statistically signiﬁcant
TABLE 2 Descriptive statistics for MIC dataa
Drug Group
MIC range
(mg/liter)
MBC50
(mg/liter)
MBC90
(mg/liter)
MIC mean
(mg/liter) (SE) Group
Mann-Whitney P value of group:
1 2 3 4
Chlorhexidine 1 2–16 4 8 5.33 (0.79) 1 NA
2 2–16 8 8 6.51 (0.42) 2 0.09 NA
3 0.5–32 8 32 14.05 (1.53) 3 <0.0001 <0.0001 NA
4 4–32 8 16 12.26 (1.27) 4 <0.0001 <0.0001 0.99 NA
Octenidine 1 0.375–0.75 0.375 0.75 0.50 (0.04) 1 NA
2 0.1875–0.75 0.75 0.75 0.56 (0.03) 2 0.25 NA
3 0.009–1.5 0.375 0.75 0.49 (0.04) 3 0.26 0.008 NA
4 0.375–1.5 0.75 1.5 0.86 (0.06) 4 <0.0001 <0.0001 <0.0001 NA
aValues indicated in bold represent a P value of 0.05. NA, not applicable. ANOVA, P  0.0001 (all groups).
TABLE 1 Number of MRSA and MSSA isolates included in each period and corresponding
biocide usage
Time period (yrs)
Biocide usage No. of isolates
Chlorhexidine Octenidine MSSA MRSA
1 (1928–1953) None None 18 0
2 (1954–2001) Minimal None 10 53
3 (2002–2012) Signiﬁcant None 1 47
4 (2013–2014) Signiﬁcant Signiﬁcant 0 31
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difference seen between these groups was for the mean chlorhexidine MBC for group
3, which was actually somewhat lower than that for group 2). There was, however, a
signiﬁcant rise in the MIC and MBC of octenidine in group 4; for example, the mean
octenidine MBC for group 4 (1 g/ml) was double that for group 3. The increase in MICs
and MBCs against isolates in group 4 appeared to be a result of an absence of isolates
with low MIC and MBC values, which were present in signiﬁcant proportions in groups
2 and 3 but absent in group 4, after the introduction of octenidine. As well as the
absence of the most susceptible isolates, there was also an emergence of isolates
requiring a higher drug MBC (3 g/ml) than was seen in the previous groups, although
three isolates with an MBC of 1.5 g/ml had been isolated at the end of the study
period for group 3 (Fig. 1 and 2). Statistically, both the MIC and MBC distributions for
octenidine seen in group 4 were signiﬁcantly different from those seen with all the
other groups (tested by chi-square or Mann-Whitney tests).
Interestingly, there was no correlation between the results with respect to suscep-
tibility to the two agents; i.e., a raised chlorhexidine MIC was not likely to be accom-
panied by a raised octenidine dihydrochloride MIC in the same isolate (tested using
Pearson’s correlation test). The changes in susceptibility to the two agents reﬂected the
usage data, although it was not possible to statistically analyze these changes.
Typing of isolates. Variable-number tandem repeat (VNTR) analysis of the isolates
revealed clonal complex 22 (CC22), which is the endemic strain within the United
Kingdom, to be the most predominant clonal complex. The other two clonal complexes
represented were CC36 and CC8 (Fig. 3).
The phylogenetic analysis failed to identify a speciﬁc clone or lineage which showed
reduced susceptibility to chlorhexidine (Fig. 3). Interestingly, overlaying susceptibility
data onto the phylogeny demonstrated several instances where isolates with the same
VNTR proﬁle differed in the MICs of both chlorhexidine and octenidine dihydrochloride,
TABLE 3 Descriptive statistics for MBC dataa
Drug Group
MBC range
(mg/liter)
MBC50
(mg/liter)
MBC90
(mg/liter)
MBC mean
(mg/liter) (SE) Group
Mann-Whitney P value of group:
1 2 3 4
Chlorhexidine 1 2–16 4 8 5.78 (0.79) 1 NA
2 2–32 8 16 8.54 (0.67) 2 0.024 NA
3 2–32 16 32 16.5 (1.63) 3 <0.0001 0.0001 NA
4 4–64 16 32 15.61 (2.21) 4 <0.0001 0.0006 0.78 NA
Octenidine 1 0.375–0.75 0.375 0.75 0.50 (0.04) 1 NA
2 0.1875–0.75 0.75 0.75 0.60 (0.03) 2 0.075 NA
3 0.1875–1.5 0.375 0.375 0.49 (0.04) 3 0.296 0.0009 NA
4 0.375–3 0.75 1.5 1.0 (0.11) 4 <0.0001 <0.0001 <0.0001 NA
aValues indicated in bold represent a P value of 0.05. NA, not applicable. ANOVA, P  0.0001 (all groups).
FIG 1 Timeline of mean MBC of chlorhexidine (blue circles) and octenidine (red circles) against isolates. The shaded
boxes represent different periods of biocide usage. A trend line (blue, linear) is shown for chlorhexidine but not
octenidine, where isolates with decreased susceptibility emerged only in the ﬁnal period.
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suggesting that the acquisition of decreased susceptibility is not restricted to one
clonal complex and that it may be able to evolve independently from various strains
(Fig. 3).
Carriage of qac genes. A total of 18/160 (11.3%) of all isolates were positive for
carriage of the qacA/B gene; apart from 1 MSSA isolate, all of these were MRSA isolates.
All of the isolates carrying the qacA/B gene had a chlorhexidine MBC of 4 g/ml. The
majority of isolates in the collection with the highest MICs and MBCs did not, however,
carry qacA/B. The highest proportion of isolates carrying the qacA/B gene (22%) was in
group 2, in contrast to groups 3 and 4, where only 6% and 8% of isolates were
carrying qacA/B. qacA/B was not detected in any of the pre-1954 isolates in group 1.
VNTR typing of all the qacA/B-positive isolates revealed that all but one of the
qacA/B-positive isolates clustered and belonged to CC8 (Fig. 3). The other isolate was
FIG 2 Chlorhexidine and octenidine MIC and MBC values for S. aureus isolates.
FIG 3 A minimum spanning tree of isolates based on VNTR proﬁles. Sizes of circles reﬂect number of isolates. Panel
A shows isolates shaded according to the MIC of chlorhexidine (in micrograms per milliliter) per the key below the
tree. Panel B shows isolates found to carry qacA/B (black circles). -ve, negative; ve, positive.
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from the sequence type 22 (ST22) cluster, and no isolates from the ST36 cluster carried
a qac gene.
Genomic analysis of ST22 isolates. Sixteen strains with related VNTR proﬁles from
groups 3 and 4 and a range of chlorhexidine MBCs were subjected to whole-genome
sequencing, and mechanisms which may contribute to decreased susceptibility to
chlorhexidine were identiﬁed. Figure 4 shows the phylogeny of these strains based on
a whole-genome alignment (generated using Roary). Comparisons of the accessory
genome content, resistance genes (analyzed by ARIBA), and presence and absence of
core genes were performed in attempts to identify common changes in those isolates
with the highest MBCs. There were no common accessory genes identiﬁed, and no
carriage of a known resistance mechanism that correlates with biocide resistance was
detected. To further try to identify a tolerance mechanism, two pairs of strains that
showed 4-fold differences in susceptibility to chlorhexidine (by MBC) but which were
very closely related according to the phylogeny data were compared for changes.
Strain 7 (MBC of 32 g/ml) was compared to strain 3 (MBC of 8 g/ml), and strain 2
(MBC of 32 g/ml) was compared to the reference ST22 isolate, HO_5096_041 (MBC
of 8 g/ml) (Fig. 4). Analysis of these strain pairs found a small number of single
nucleotide polymorphisms (SNPs) in each pair (5 SNPs for the ﬁrst pair and 20 SNPs for
the second pair). The two more resistant isolates both had changes in one of two
homologous efﬂux pump systems, NorA and NorB. Both have been shown to export
multiple agents, including biocides (22). Strain 2 carried an SNP within norB that
resulted in a change of the NorB protein of Met314Ile. This substitution is adjacent to
the predicted translocation pore and may alter the capacity of this strain to export
chlorhexidine compared to the reference strain. Strain 7 had a wild-type norB allele but
carried an SNP within norA that resulted in a change in NorA of Ala362Val. Substitution
at this site has previously been shown to improve the efﬂux capacity of the protein for
some substrates (23). None of the other sequenced strains had changes within either
system or in their known regulators.
FIG 4 Visualization of pan-genome analysis by Roary of 16 isolates. Hospital and year of isolation are indicated as well as chlorhexidine (CHX) MBC.
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DISCUSSION
This study highlighted the ﬁnding that the increasing use of chlorhexidine and
octenidine dihydrochloride is associated with emergence of reduced susceptibility to
each agent in S. aureus. As described in previous studies (15, 24), the number of
S. aureus isolates (and especially MRSA isolates) that have demonstrated reduced
susceptibility to chlorhexidine has increased over time, which in the current study was
most marked when the MRSA epidemic was at its peak within the United Kingdom.
There have only been a limited number of studies that have investigated reduced
susceptibility to chlorhexidine longitudinally, and all had examined shorter time peri-
ods. Historical isolates included in this study from a period of no antiseptic usage had
very low MIC and MBC values, and increases were then observed in groups 2 and 3.
Interestingly, in contrast to other longitudinal studies where there have been similar
observations, the increases in MIC and MBC values that we observed for chlorhexidine
plateaued in the fourth time period. This may reﬂect the reduction in the number of
MRSA infections within the United Kingdom in that most recent time period and the
consequent reduction in chlorhexidine usage in our hospital.
We also demonstrated a reduction in susceptibility to octenidine following its
universal introduction. There have been a limited number of studies investigating the
clinical efﬁcacy of octenidine dihydrochloride, which, while the data were limited,
demonstrated efﬁcacy comparable to that of chlorhexidine, but those studies did not
include susceptibility testing as part of the analyses (13, 14). There has been very little
in vitro work investigating the potential development of resistance to octenidine,
although one study did attempt to select for resistant mutants (without success) (12).
While there was a demonstrable reduction in susceptibility in isolates seen in the
current study and while this markedly occurred after the introduction of octenidine into
practice, the MIC and MBC are still relatively low and signiﬁcantly below the concen-
trations at which the antiseptics are used in practice. It is unclear what impact these
relatively small changes in tolerance as measured in vitro have in practice. Comparing
the MIC values to the in-use concentrations suggests that it is unlikely that these
isolates will affect clinical efﬁcacy, but they have emerged in a real-world situation,
suggesting that there is a signiﬁcant beneﬁt which has been selected in practice.
Interestingly, isolates with decreased susceptibility to octenidine dihydrochloride
emerged within the ﬁrst year of its introduction into clinical practice.
For both biocides, isolates with decreased susceptibility were not clonal, which
suggests that there has been no emergence of a dominant clone with an advantage in
the face of either biocide. The fact that isolates with decreased susceptibility are seen
in various strain backgrounds suggests that the capacity to develop this phenotype is
common to many strains and presumably results from a change in the S. aureus core
genome. This differs from previous reports of the spread of a dominant clone with
reduced susceptibility (20).
As highlighted by the review by Harbarth and colleagues, the increased usage of
antiseptics has not been matched by an increase in surveillance (both microbiological
and clinical) (25). One of the reasons for the lack of surveillance is the lack of both
standardized testing methodology and deﬁnitions for resistance. The majority of
studies have utilized MICs, but the methodologies vary and the technique is less
applicable for antiseptics where the lethal concentration rather than the inhibitory
concentration needs to be measured and MBC testing is more meaningful. As there is
no standardized testing methodology, there has been no national or international
agreement regarding an appropriate cutoff value for deﬁning resistance. The clinical
impact of the reduced susceptibility demonstrated in vitro also needs to be assessed,
with the concentrations of antiseptics measured in vitro being much lower than the
concentrations of antiseptics achieved in vivo.
Epidemiological typing in this study revealed that isolates with high MICs are spread
across VNTR proﬁles, both in ST22 (the predominant epidemic clone observed in the
United Kingdom) and in CC8. In comparisons performed to detect the presence of
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qacA/B, there was no correlation with chlorhexidine susceptibility; the majority of
qacA/B isolates were from CC8. This clonal complex contains ST239, which has previ-
ously been described as carrying the qacA/B genes and has been associated with
clinical failure of chlorhexidine (21). Carriage of qacA/B was seen in only one ST22
isolate in our panel, which is the most predominant ST both within the study hospital
and in the United Kingdom. Despite the lack of carriage of qacA/B in ST22 isolates, the
number of isolates with raised MICs was the same as among those from the CC8 group,
highlighting further the lack of correlation between the presence of qacA/B and
reduced susceptibility to chlorhexidine.
Consistent with the lack of correlation of qacAB carriage and antiseptic susceptibil-
ity, a genomic analysis of a subset of strains revealed no common mobile element
which could be shown to be associated with chlorhexidine susceptibility. In two pairs
of isolates with different chlorhexidine MICs, mutations within chromosomal multidrug
efﬂux systems norA and norB were found. NorA and NorB have previously been
associated with chlorhexidine tolerance for isolates that overexpress these systems,
demonstrating decreased chlorhexidine susceptibility (22, 24, 26), although another
study reported only a weak association (27). Both norA and norB are part of the core
S. aureus genome, which is consistent with our observation that decreased suscepti-
bility to chlorhexidine can emerge from multiple lineages and is not conditional on
horizontal acquisition of qacA/B. Previous studies have focused on changes in expres-
sion of efﬂux systems as a mechanism to increase the efﬁciency of export of substrates.
Mutation within the structural pump protein of a multidrug efﬂux system was also
recently shown to increase the efﬁciency of export of some substrates at the expense
of others (28). The substitutions within NorB (adjacent to the translocation pore) and
NorA (known to alter pump efﬁciency for ﬂuoroquinolone export) identiﬁed here may
reﬂect adaptations to increase the efﬁciency of chlorhexidine export.
The signiﬁcance and clinical impact of the emergence of isolates with decreased
susceptibility to decolonization regimes remain uncertain. However, our data show that
the susceptibility of the studied S. aureus population to antiseptics has shifted over
time. It is not possible to demonstrate from these data a causative link between
antiseptic use and changes in susceptibility, although differences in antiseptic usage
and population sensitivities were seen in conjunction. There is an obvious need for
more research in this area to provide better surveillance data from larger populations
and geographic regimes and to understand the mechanisms of action and resistance to
antiseptics better.
MATERIALS AND METHODS
A panel of 160 non-methicillin-resistant and methicillin-resistant S. aureus strains isolated between
1928 and 2014 was included in the study (Table 1). This panel included some of the earliest MRSA isolates
from the 1960s and 1970s, from the National Collection of Type Cultures (NCTC). All MRSA isolates from
2002 onward were collected from one large NHS Trust hospital in the West Midlands of the United
Kingdom. Since 2002, the hospital has had a policy of prescribing a 5-day course of chlorhexidine to
decolonize all known MRSA-positive patients. In 2014, universal washing of all patients with octenidine
dihydrochloride for the duration of their hospital stay was implemented, with those patients identiﬁed
as being colonized by or infected with MRSA continuing to receive chlorhexidine.
In this study, both screening and clinical isolates were included. The isolates were grouped into four
panels (Table 1) to reﬂect the usage of octenidine dihydrochloride and chlorhexidine from 1928 to 2014
(groups 1 to 4). The ﬁrst group comprised 18 MSSA isolates from 1928 to 1953, during which time there
was no use of either antiseptic, and provided the historical context for susceptibility of populations
unexposed to antiseptics. The second group comprised 53 MRSA isolates and 10 MSSA isolates from 1954
to 2001, during which time there was low usage of chlorhexidine and no usage of octenidine. The third
group contained 1 MSSA isolate and 47 MRSA isolates from 2002 to 2012, during which time chlorhexi-
dine usage was high but octenidine was not used. The ﬁnal group contained 31 MRSA isolates from 2013
to 2014, during which time there was high use of chlorhexidine and octenidine had been introduced. The
dominance of MRSA isolates over MSSA isolates reﬂects routine surveillance practice, where MRSA are
actively identiﬁed in patients on admission but MSSA are not.
The MICs of each agent were determined using broth microdilution (following recommendations
from EUCAST) ranging in concentration from 0.0029 g/ml to 3 g/ml for octenidine dihydrochloride
and 0.0625 g/ml to 64 g/ml for chlorhexidine digluconate. Minimum bactericidal concentrations
(MBC) were subsequently determined by inoculation of 10 l of suspensions (following determinations
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of MICs) onto LB agar and observation of growth after overnight incubation. The presence of qacA/B was
determined in all samples using multiplex PCR (26).
A panel of 99/160 isolates, including all qacA/B-positive isolates and all isolates from groups 3 and
4, was epidemiologically typed using variable-number tandem repeat analysis as previously described
(29). Genomes of a selection of 16 isolates from groups 3 and 4 that included the main circulating clones
were also sequenced using Illumina paired-end sequencing. Reads were then analyzed using the
nullarbor pipeline (v1.2 [30]) and a standard virtual machine on the MRC CLIMB framework. Pan-genomes
were generated using Roary (v8.0), SNPs were called with Snippy (v3.0), and antibiotic resistance genes
and mutations were identiﬁed using ARIBA (v2.8.1). Trees were visualized with Phandango. All packages
used default parameters unless stated otherwise.
Data were obtained for the number of packs of chlorhexidine and octenidine dihydrochloride issued
by the pharmacy in the large teaching NHS Trust hospital from 2008 to 2014, the time period the MRSA
isolates were obtained from. Statistical analyses of changes in susceptibility patterns between groups
used analysis of variance (ANOVA) (Kruskal-Wallis test), chi-square, and Mann-Whitney tests.
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